Race Oncology Board of Directors, Key People and Executives

Health Care & Life Sciences » Pharmaceuticals | Race Oncology Ltd.

Race Oncology Ltd. | Key People and Executives

William J. Garner

Chairman

Peter Laurence Molloy

Chief Executive Officer, Director & MD

John Cullity

Non-Executive Director

Chris Ntoumenopoulos

Non-Executive Director

William J. Garner

Chairman

Peter Laurence Molloy

Chief Executive Officer, Director & MD

Samar Al-Behaisi

Chief Medical Officer & VP-Medical Affairs

John M. Rothman

Chief Scientific Officer

Gordon Beck

Senior Vice President-Business Development

John Cullity

Non-Executive Director

Chris Ntoumenopoulos

Non-Executive Director

Peter Gordon Webse

Secretary

View Profile

Address	710 Collins Street Docklands Victoria (VIC) 3008 Australia
Employees	-
Website	http://www.raceoncology.com
Updated	07/08/2019
Race Oncology Ltd is a pharmaceutical company, whose business model is to pursue later stage drug assets, principally in the cancer field. Its first important asset is a chemotherapy drug, called Bisantrene, which is used as the first line of treatment for Acute Myeloid Leukaemia and many other cancers. The company was founded on February 15, 2011 and is headquartered in Docklands, Australia.